Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN

PHASE3CompletedINTERVENTIONAL
Enrollment

516

Participants

Timeline

Start Date

July 23, 2020

Primary Completion Date

December 7, 2021

Study Completion Date

January 25, 2022

Conditions
Diabetic Peripheral Neuropathy (DPN)Paresthesia
Interventions
DRUG

Acetyllevocarnitine Hydrochloride Tablets

500 mg (2×250 mg/tablet) after meal, 3 times per day

DRUG

Placebo

500 mg (2×250 mg/tablet) after meal, 3 times per day

Trial Locations (34)

Unknown

Guangzhou First People's Hospital, Guangzhou

Huizhou Central People's Hospital, Huizhou

Affiliated Hospital of Zunyi Medical University, Zunyi

Hainan Third People's Hospital, Sanya

Handan Central Hospital, Handan

Hebei Petro China Center Hospital, Langfang

The Fourth Affiliated Hospital of Harbin Medical University, Harbin

Huaihe Hospital of Henan University, Kaifeng

Kaifeng Traditional Chinese Medicine Hospital, Kaifeng

Luoyang Third People's Hospital, Luoyang

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang

Xinxiang First People's Hospital, Xinxiang

Henan Provincial People's Hospital, Zhengzhou

The Medical Group of Zhengzhou First People's Hospital, Zhengzhou

The Second Affiliated Hospital of Zhengzhou University, Zhengzhou

Taihe Hospital, Shiyan

Affiliated Hospital of Nantong University, Nantong

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

Jiujiang Traditional Chinese Medicine Hospital, Jiujiang

The Fourth Affiliated Hospital of Nanchang University, Nanchang

Yichun People's Hospital, Yichun

Affiliated Hospital of Yanbian University, Yanbian

The First People's Hospital of Yinchuan, Yinchuan

Binzhou Medical University Hospital, Binzhou

Qingdao Central Hospital, Qingdao

Weihai Central Hospital, Weihai

Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou

The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou

Beijing Hospital, Beijing

Beijing Luhe Hospital, Capital Medical University, Beijing

Beijing Pinggu Hospital, Beijing

Chongqing People's Hospital, Chongqing

Yongchuan Hospital of Chongqing Medical University, Chongqing

Tianjin First Central Hospital, Tianjin

All Listed Sponsors
lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY

NCT05319275 - Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN | Biotech Hunter | Biotech Hunter